Benefits and costs of methadone treatment: results from a lifetime simulation model.
about
Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction StrategiesA systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problemsOpioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.Did we get our money's worth? Bridging economic and behavioral measures of program success in adolescent drug preventionCharacterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users.Conducting economic evaluations of screening and brief intervention for hazardous drinking: Methods and evidence to date for informing policy.Methadone treatments in a Swiss region, 2001-2008: a registry-based analysis.Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model.Can discrete event simulation be of use in modelling major depression?Dynamics in the costs of criminality among opioid dependent individuals.The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.Needed: Longitudinal Research That Can Inform Dynamic Models for the Treatment of Addiction as a Disease.A call for evidence-based medical treatment of opioid dependence in the United States and Canada.Evidence-based drug policy: it starts with good evidence and ends with policy reform.The causal effect of opioid substitution treatment on HAART medication refill adherenceIndividual and system influences on waiting time for substance abuse treatment.Characterizing durations of heroin abstinence in the California Civil Addict Program: results from a 33-year observational cohort studyTreating drug abuse and addiction in the criminal justice system: improving public health and safety.What are your priorities right now? Identifying service needs across recovery stages to inform service development.Medical profiteering: the economics of methadone dispensationInterim versus standard methadone treatment: a benefit-cost analysis.A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence.Economic evaluations of contingency management in illicit drug misuse programmes: A systematic review.Hurdles that impede economic evaluations of welfare interventions.Trust, agency and control: Perspectives on methadone takeaway dosing in the context of the Victorian policy review.Estimating State Transitions for Opioid Use Disorders.Employment among chronic drug users at baseline and 6-month follow-up.The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients.The costs of crime associated with stimulant use in a Canadian setting.Continuous time simulation and discretized models for cost-effectiveness analysis.Stigma from the Viewpoint of the Patient.
P2860
Q26785478-3B67AD82-778D-4A0D-9E7E-FA0A87726EE0Q28072735-8836420A-F5B6-49C1-A34B-5F13982A0BE8Q30249760-D6D26AC8-A849-4342-B8D5-16B29AB9ECF0Q30392677-499CA8F7-0E1C-4C4A-9BC3-10E1527BD5D2Q33810775-2639BD57-16C5-43D9-96BF-C0FC38B8EAB5Q34248510-A36BED67-F295-46A3-80D2-846A30DB35A2Q34523541-2EFCB0F4-8A0B-4434-A066-68D58F3CA79BQ35190714-4AE74001-4175-480D-B9C9-E40CBB5700DDQ35568861-FB6DA5DE-364E-4BAE-9541-A1B7BD72C011Q35684512-D25525E7-6DBD-4774-B4D0-F873A7A85823Q35726267-89E14D61-8D20-41AB-BB47-07605ED69450Q35795201-82CB143E-0DCB-40B8-9BA2-E9F58465791AQ35855933-C87B9C22-DBA6-4721-B5A1-BE82FB2A24E3Q36062082-B049A8C5-EBEF-4009-AA98-D6231D9B499CQ36062087-7A289221-C4DE-42B1-AE59-494C41B2EB74Q36093606-E126E4FA-8DA5-464A-9086-ABE20F4C7871Q36498680-6A568B33-D358-42D1-A0C5-D0AE369E8ED1Q36854061-474CF10C-F1C7-4456-B41A-FDF20C26CDD4Q37189427-339B08BD-45EA-417F-8664-36EDA6D47324Q37463778-BCBC1B03-8B7F-4133-9389-9703AFFDB8F3Q37495314-FC755CB9-9E22-4280-B6F9-1595AB63BEFFQ37625610-9E6649D4-7B23-42A8-91C5-9C09DF30A634Q37663311-7FF94116-5740-496E-9365-1382A6CCF15CQ38347049-86773501-A4D8-4D33-B487-7384EDD67D04Q38472247-915C2643-1839-4E01-B3B6-F18D38545DDFQ38530541-ECA58ECA-04D3-461A-820F-3563E68C3E4DQ39062397-5493AAFF-85D1-49B2-AF63-992D5194D513Q40187763-FEEEAE72-D24F-4236-B8BD-0E93A258174BQ43131867-1A44528F-8094-465E-B448-F07678128398Q47615115-106918C7-DCDB-401D-AC4C-E49BA04C186BQ49054829-7261BF1B-0682-40A7-9D95-58A7471BE7DAQ50904014-7CD23608-107C-4930-A1FD-C915AE79A9AB
P2860
Benefits and costs of methadone treatment: results from a lifetime simulation model.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Benefits and costs of methadone treatment: results from a lifetime simulation model.
@en
Benefits and costs of methadone treatment: results from a lifetime simulation model.
@nl
type
label
Benefits and costs of methadone treatment: results from a lifetime simulation model.
@en
Benefits and costs of methadone treatment: results from a lifetime simulation model.
@nl
prefLabel
Benefits and costs of methadone treatment: results from a lifetime simulation model.
@en
Benefits and costs of methadone treatment: results from a lifetime simulation model.
@nl
P2093
P356
P1433
P1476
Benefits and costs of methadone treatment: results from a lifetime simulation model
@en
P2093
Daniel Mamo
Katherine A Hicks
Laura J Dunlap
P2860
P304
P356
10.1002/HEC.999
P407
P50
P577
2005-11-01T00:00:00Z